139 related articles for article (PubMed ID: 9614567)
21. Targeted transgene expression in rat brain using lentiviral vectors.
Jakobsson J; Ericson C; Jansson M; Björk E; Lundberg C
J Neurosci Res; 2003 Sep; 73(6):876-85. PubMed ID: 12949915
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
23. Brain-specific expression of an exogenous gene after i.v. administration.
Shi N; Zhang Y; Zhu C; Boado RJ; Pardridge WM
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12754-9. PubMed ID: 11592987
[TBL] [Abstract][Full Text] [Related]
24. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
[TBL] [Abstract][Full Text] [Related]
25. Glioma/glioblastoma-specific adenoviral gene expression using the nestin gene regulator.
Kurihara H; Zama A; Tamura M; Takeda J; Sasaki T; Takeuchi T
Gene Ther; 2000 Apr; 7(8):686-93. PubMed ID: 10800092
[TBL] [Abstract][Full Text] [Related]
26. Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter.
Danks RA; Orian JM; Gonzales MF; Tan SS; Alexander B; Mikoshiba K; Kaye AH
Cancer Res; 1995 Oct; 55(19):4302-10. PubMed ID: 7671240
[TBL] [Abstract][Full Text] [Related]
27. Development of a second-generation oncolytic Herpes simplex virus expressing TNFalpha for cancer therapy.
Han ZQ; Assenberg M; Liu BL; Wang YB; Simpson G; Thomas S; Coffin RS
J Gene Med; 2007 Feb; 9(2):99-106. PubMed ID: 17256802
[TBL] [Abstract][Full Text] [Related]
28. Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury.
Mucke L; Oldstone MB; Morris JC; Nerenberg MI
New Biol; 1991 May; 3(5):465-74. PubMed ID: 1883812
[TBL] [Abstract][Full Text] [Related]
29. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
[TBL] [Abstract][Full Text] [Related]
30. Nuclear factor-I regulates glial fibrillary acidic protein gene expression in astrocytes differentiated from cortical precursor cells.
Cebolla B; Vallejo M
J Neurochem; 2006 May; 97(4):1057-70. PubMed ID: 16606365
[TBL] [Abstract][Full Text] [Related]
31. Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancer therapy.
Parkinson RJ; Mian S; Bishop MC; Gray T; Li G; McArdle SE; Ali S; Rees RC
Prostate; 2003 Jun; 56(1):65-73. PubMed ID: 12746848
[TBL] [Abstract][Full Text] [Related]
32. Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain.
Thomas CE; Birkett D; Anozie I; Castro MG; Lowenstein PR
Mol Ther; 2001 Jan; 3(1):36-46. PubMed ID: 11162309
[TBL] [Abstract][Full Text] [Related]
33. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
[TBL] [Abstract][Full Text] [Related]
34. Primary astrocytes retrovirally transduced with a tyrosine hydroxylase transgene driven by a glial-specific promoter elicit behavioral recovery in experimental parkinsonism.
Cortez N; Trejo F; Vergara P; Segovia J
J Neurosci Res; 2000 Jan; 59(1):39-46. PubMed ID: 10658184
[TBL] [Abstract][Full Text] [Related]
35. Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant.
Mineta T; Rabkin SD; Martuza RL
Cancer Res; 1994 Aug; 54(15):3963-6. PubMed ID: 8033122
[TBL] [Abstract][Full Text] [Related]
36. Live astrocytes visualized by green fluorescent protein in transgenic mice.
Zhuo L; Sun B; Zhang CL; Fine A; Chiu SY; Messing A
Dev Biol; 1997 Jul; 187(1):36-42. PubMed ID: 9224672
[TBL] [Abstract][Full Text] [Related]
37. Targeted gene therapy toward astrocytoma using a Cre/loxP-based adenovirus system.
Maeda M; Namikawa K; Kobayashi I; Ohba N; Takahara Y; Kadono C; Tanaka A; Kiyama H
Brain Res; 2006 Apr; 1081(1):34-43. PubMed ID: 16529724
[TBL] [Abstract][Full Text] [Related]
38. Potential and limitations of a gamma 34.5 mutant of herpes simplex 1 as a gene therapy vector in the CNS.
McMenamin MM; Byrnes AP; Pike FG; Charlton HM; Coffin RS; Latchman DS; Wood MJ
Gene Ther; 1998 May; 5(5):594-604. PubMed ID: 9797863
[TBL] [Abstract][Full Text] [Related]
39. Tumor-specific transcriptional targeting of suicide gene therapy.
Qiao J; Doubrovin M; Sauter BV; Huang Y; Guo ZS; Balatoni J; Akhurst T; Blasberg RG; Tjuvajev JG; Chen SH; Woo SL
Gene Ther; 2002 Feb; 9(3):168-75. PubMed ID: 11859419
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
